Thursday

27th Apr 2017

Resignation at EU drugs agency highlights ethics issues

  • Conflict of interests have to be properly managed to maintain consumers' trust, say consumer groups (Photo: Bart)

A top scientist within the EU agency authorising new drugs resigned on Wednesday (4 April) after being fired from France's national regulator, itself embroiled in scandals over poisonous diabetes drugs and failing breast implants.

Eric Abadie, a French specialist in diabetes and heart-related diseases, had for the past five years been chaired a panel of experts giving scientific advice to the European Medicines Agency on authorising the sale of new drugs on the EU market.

Dear EUobserver reader

Subscribe now for unrestricted access to EUobserver.

Sign up for 30 days' free trial, no obligation. Full subscription only 15 € / month or 150 € / year.

  1. Unlimited access on desktop and mobile
  2. All premium articles, analysis, commentary and investigations
  3. EUobserver archives

EUobserver is the only independent news media covering EU affairs in Brussels and all 28 member states.

♡ We value your support.

If you already have an account click here to login.

"I am not aware of any criminal charges made against Dr Abadie," Martin Harvey, a spokesman for the London-based EU agency told this website, adding that his resignation was linked to the other job Abadie was holding as top scientific adviser of France's national medicines regulatory body.

The spokesman explained that "almost all" experts sitting on the EU panel have a similar role at national level. "This does not present a conflict of interests in that it is important that the European and national agencies work together closely," Harvey said.

The French agency meanwhile has come under intense scrutiny for not having withdrawn authorisation for "Mediator", a diabetes drug - Abadie's field of expertise according to his CV - that was already banned in other countries and that is blamed for having killed at least 500 patients in France. Since December, the agency is also being accused of having given a green light to faulty breast implants filled with poisonous industrial silicone made by the now bankrupt French producer PIP.

A spokeswoman for the French agency told this website that Abadie's resignation is due to the fact that his post was scrapped during a 're-organisation' of the agency decided in December - at the peak of the PIP breast implants scandal. She refused to comment on the link between the scandal and Abadie's scientific advice.

"He decided to resign because his position within the EU agency was paid for by the French government and because the director of the EU agency did not give a favourable answer to taking over his salary," she explained.

The EU medicines agency already has come under fire for having turned a blind eye to close links to the pharma industry, with its former director resigning at the end of 2010 to go and work as a consultant for the drug industry only a few days later.

Last month, MEPs in the budgetary control committee refused to sign off the agency's accounts for 2010 over conflict of interest issues.

"The Abadie case is yet another example of the need to have independent experts working only for the EU agency and not for national bodies or other organisations. Conflict of interests are not only an opportunity for the industry to bend rules according to their needs, but can also endanger public safety," Romanian MEP Monica Macovei who drafted the parliament's position on the issue told this website.

Consumer protection groups have also rallied behind her. "We try to encourage these agencies to make an effort and resolve conflicts of interest, which are bad for consumers," said Jonathan La Morte from Beuc, the European umbrella organisation for consumer protection groups.

In a position paper sent to the European Parliament last month, Beuc stressed that the "effective management of conflict of interests are crucial to maintain consumers’ trust in the independence and in the quality of the scientific opinions of EMA and ultimately in the safety of the medicines they use."

MEPs divided on whether to punish EU agencies

MEPs are getting ready to vote on whether to punish three EU agencies for using public money for questionable purposes and for tolerating conflicts of interest.

Eurozone bank needs more scrutiny, says NGO

Transparency International says eurozone's central bank is not subject to "appropriate democratic scrutiny" and should have no say on EU bailout projects.

Analysis

From Bratislava to Rome: Little more than a show of unity

The so-called Bratislava process of reflection for the EU came to an end on Saturday, but there were few tangible results that citizens could take away from the soul-searching. Despite that, unity among the EU-27 has been maintained.

Column / Brexit Briefing

Controlling the right of repeal

There was a distinct air of finality about Sir Tim Barrow's personal delivery of the Article 50 letter in Brussels – it certainly marks the end of an era.

Be fair in Brexit talks, EU tells UK

European Council chief Tusk sent draft guidelines to member states. He said the EU wants "fairness" and then warned against using security cooperation as bargaining chip.

News in Brief

  1. EU parliament moves to lift Le Pen's immunity
  2. EU Commission launches probe into Hungary's university law
  3. Scots slowly losing appetite for independence - poll
  4. Council of Europe puts Turkey on watch list
  5. EU to put parental leave on political agenda
  6. Israel cancels German meeting over human rights groups
  7. Hungary's Orban will participate in EU parliament debate
  8. Malta floats cash-for-refugees plan

Stakeholders' Highlights

  1. UNICEFRace Against Time to Save Millions of Lives in Yemen
  2. Nordic Council of MinistersDeveloping Independent Russian-Language Media in the Baltic Countries
  3. Swedish EnterprisesReform of the European Electricity Market: Lessons from the Nordics, Brussels 2 May
  4. Malta EU 2017Green Light Given for New EU Regulation to Bolster External Border Checks
  5. Counter BalanceCall for EU Commission to Withdraw Support of Trans-Adriatic Pipeline
  6. ACCAEconomic Confidence at Highest Since 2015
  7. European Federation of Allergy and Airways60%-90% of Your Life Is Spent Indoors. How Does Poor Indoor Air Quality Affect You?
  8. European Gaming and Betting AssociationCJEU Confirms Obligation for a Transparent Licensing Process
  9. Nordic Council of MinistersNordic Region and the US: A Time of Warlike Rhetoric and Militarisation?
  10. European Free AllianceEFA MEPs Vote in Favor of European Parliament's Brexit Mandate
  11. Mission of China to the EUXinhua Insight: China to Open up Like Never Before
  12. World VisionViolence Becomes New Normal for Syrian Children

Latest News

  1. EU starts legal action against Hungary
  2. Brexit is about Europe's future as well
  3. Power struggle in Greenland: Three reasons why the EU should care
  4. Nordic and Baltic countries step up digitalisation efforts
  5. European states still top media freedom list
  6. Let’s not put European public health at risk
  7. Threatened Budapest university calls for EU support
  8. Orban set to face down EU threats